J S Kenney - Concepedia

Author

J S Kenney

Cornell University

Also Known As

J S Kenney, J. Kenney, J.S. Kenney, JS Kenney

Publications

Citations

H-Index

Concepts

All Affiliations

Cornell University NewYork–Presbyterian Hospital Hôpital d'Hautepierre University of Florida Hôpitaux Universitaires de Strasbourg

About

J S Kenney is an author at Cornell University specializing in medicine, inflammation, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	2.1K
2	Health Sciences	1	1	368
3	Cell Biology	1	1	650
4	Diabetes	1	1	368
5	Endocrinology	1	1	368

J S Kenney

Publications

Citations

H-Index

Page 1

	Year	Citations
Evidence for the involvement of interleukin 6 in experimental cancer cachexia. Gideon Strassmann, M Fong, J S Kenney, Journal of Clinical Investigation ImmunologyCell DeathPathologyImmunologic MechanismImmunotherapy	1992	650
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. Yuman Fong, Kevin J. Tracey, Lyle L. Moldawer, The Journal of Experimental Medicine Microbial PathogensHumoral ResponseImmunologyPathologyImmunologic Mechanism	1989	644
The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. Yuman Fong, Michael A. Marano, Lyle L. Moldawer, Journal of Clinical Investigation NutritionAcute SplanchnicToxicological MechanismDisease PhysiologyInflammation	1990	368
Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. E Fischer, Michael A. Marano, Kimberly J. Van Zee, Journal of Clinical Investigation InflammationIl-1 Receptor AntagonistCytokineHost ResponseIl-1 Beta	1992	334
IL-8 in septic shock, endotoxemia, and after IL-1 administration Kimberly J. Van Zee, Laura DeForge, E Fischer, The Journal of Immunology	1991	308
Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. J.M. Reimund, C Wittersheim, Serge Dumont, Gut	1996	300
Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease E Fischer, KJ Van Zee, MA Marano, Blood	1992	211
In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease. J.M. Reimund, Serge Dumont, Christian D. Muller, Gut	1997	77
A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon. M. Burress Welborn, K. Van Zee, P. Edwards, The Journal of Experimental Medicine T-regulatory CellImmune RegulationImmunologyCell DeathPathology	1996	56
PEG-BP-30 Monotherapy Attenuates the Cytokine-Mediated Inflammatory Cascade in Baboon Escherichia coli Septic Shock N. Joseph Espat, Juan Cendán, Elizabeth A. Beierle, Journal of Surgical Research	1995	46

Page 1